Caprolactam Chemicals Intrinsic Value
Caprolactam Chemicals intrinsic value. Caprolactam Chemicals (CAPRO) median intrinsic value is ₹24.00 from 4 valuation models (range ₹13–₹37), vs current price ₹43.95 — -45.4% downside (Trading Above Calculated Value), margin of safety -83.1%. Browse CAPRO financial statements for revenue, profit, balance sheet and cash flow data.
CAPRO Valuation Methods Summary — DCF, Graham Number & P/E
Caprolactam Chemicals intrinsic value across 4 models vs current price ₹43.95 — upside/downside and value range per method. Analyse CAPRO promoter holding to track promoter, FII and institutional holdings.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹14.00 | ₹12.60 - ₹15.40 | -68.1% | Book Value/Share: ₹14.00, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹13.19 | ₹11.87 - ₹14.51 | -70.0% | Revenue/Share: ₹12.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹24.00 | ₹21.60 - ₹26.40 | -45.4% | EBITDA: ₹2.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹37.14 | ₹29.71 - ₹44.57 | -15.5% | CF Growth: 5.0%, Discount: 15% |
CAPRO Intrinsic Value vs Market Price — All Valuation Models
Caprolactam Chemicals fair value range ₹13–₹37 vs current market price ₹43.95 across 4 valuation models. For current market price and key ratios, visit Caprolactam Chemicals stock price NSE.
CAPRO Intrinsic Value Analysis — Undervalued or Overvalued?
Caprolactam Chemicals median intrinsic value ₹24.00, current price ₹43.95 — Trading Above Calculated Value by 45.4%, margin of safety -83.1%.
What is the intrinsic value of CAPRO?
Based on our comprehensive analysis using 4 different valuation methods, the estimated intrinsic value of Caprolactam Chemicals (CAPRO) is ₹24.00 (median value). With the current market price of ₹43.95, this represents a -45.4% variance from our estimated fair value.
The valuation range spans from ₹13.19 to ₹37.14, indicating ₹13.19 - ₹37.14.
Is CAPRO undervalued or overvalued?
Based on our multi-method analysis, Caprolactam Chemicals (CAPRO) appears to be trading above calculated value by approximately 45.4%.
CAPRO Financial Health — Key Ratios vs Industry Benchmarks
Caprolactam Chemicals financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | -14.3% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -103.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.35x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
CAPRO Cash Flow Quality — Operating & Free Cash Flow
Caprolactam Chemicals operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹2 Cr | ₹2 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹-1 Cr | ₹-2 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹2 Cr | ₹1 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹1 Cr | ₹0 Cr | Positive Operating Cash Flow | 6/10 |
| March 2022 | ₹3 Cr | ₹1 Cr | Positive Free Cash Flow | 7/10 |